11296162

Source:http://linkedlifedata.com/resource/pubmed/id/11296162

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0004096, umls-concept:C0021368, umls-concept:C0030705, umls-concept:C0205360, umls-concept:C0439234, umls-concept:C0547040, umls-concept:C1522577
pubmed:issue	4
pubmed:dateCreated	2001-4-11
pubmed:abstractText	To determine the time to exacerbation and probability of a mild exacerbation of asthma, and the impact of eosinophilic inflammation on these parameters in patients with stable, well-controlled asthma.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0231335
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic beta-Agonists, http://linkedlifedata.com/resource/pubmed/chemical/Anti-Inflammatory Agents, http://linkedlifedata.com/resource/pubmed/chemical/Blood Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Bronchodilator Agents, http://linkedlifedata.com/resource/pubmed/chemical/Budesonide, http://linkedlifedata.com/resource/pubmed/chemical/Eosinophil Granule Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Glucocorticoids, http://linkedlifedata.com/resource/pubmed/chemical/Methacholine Chloride, http://linkedlifedata.com/resource/pubmed/chemical/Ribonucleases
pubmed:status	MEDLINE
pubmed:month	Apr
pubmed:issn	0012-3692
pubmed:author	pubmed-author:BeldaJJ, pubmed-author:CasanPP, pubmed-author:GinerJJ, pubmed-author:SanchisJJ
pubmed:issnType	Print
pubmed:volume	119
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1011-7
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:11296162-Administration, Inhalation, pubmed-meshheading:11296162-Administration, Topical, pubmed-meshheading:11296162-Adolescent, pubmed-meshheading:11296162-Adrenergic beta-Agonists, pubmed-meshheading:11296162-Adult, pubmed-meshheading:11296162-Aged, pubmed-meshheading:11296162-Anti-Inflammatory Agents, pubmed-meshheading:11296162-Asthma, pubmed-meshheading:11296162-Blood Proteins, pubmed-meshheading:11296162-Bronchial Provocation Tests, pubmed-meshheading:11296162-Bronchodilator Agents, pubmed-meshheading:11296162-Budesonide, pubmed-meshheading:11296162-Eosinophil Granule Proteins, pubmed-meshheading:11296162-Eosinophils, pubmed-meshheading:11296162-Follow-Up Studies, pubmed-meshheading:11296162-Forced Expiratory Volume, pubmed-meshheading:11296162-Glucocorticoids, pubmed-meshheading:11296162-Humans, pubmed-meshheading:11296162-Inflammation, pubmed-meshheading:11296162-Leukocyte Count, pubmed-meshheading:11296162-Longitudinal Studies, pubmed-meshheading:11296162-Methacholine Chloride, pubmed-meshheading:11296162-Middle Aged, pubmed-meshheading:11296162-Peak Expiratory Flow Rate, pubmed-meshheading:11296162-Ribonucleases, pubmed-meshheading:11296162-Risk Factors
pubmed:year	2001
pubmed:articleTitle	Mild exacerbations and eosinophilic inflammation in patients with stable, well-controlled asthma after 1 year of follow-up.
pubmed:affiliation	Hospital de la Santa Creu i Sant Pau, Barcelona, Catalunya, Spain.
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't